This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Medimmune Limited. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: David Phillip Monk: Innovator in IgE Binding Members
Introduction
David Phillip Monk is a notable inventor based in Southampton, GB. He has made significant contributions to the field of biotechnology, particularly in the development of binding members for IgE molecules. His work is crucial for advancing treatments for disorders mediated by IgE, such as allergies and asthma.
Latest Patents
David Phillip Monk holds 1 patent for his invention titled "Binding members for IgE molecules." This invention focuses on antibody molecules that can effectively bind to IgE, providing potential therapeutic benefits for individuals suffering from IgE-mediated conditions.
Career Highlights
David is currently associated with Medimmune Limited, a prominent company in the biopharmaceutical sector. His role at Medimmune has allowed him to engage in innovative research and development, contributing to the advancement of medical treatments.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues, including Karin Von-Wachenfeldt and Duncan James Cochrane. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
David Phillip Monk's contributions to the field of biotechnology, particularly in IgE binding members, highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to pave the way for advancements in treating allergies and asthma.